HIGHLIGHTS
- who: Yanning Wang et al. from the Clinical Stem Cell Center, The Affiliated Drum Tower Hospital of University Medical School, China have published the research: Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer, in the Journal: (JOURNAL) of 11/02/2022
- how: The updated meta-analysis included a total of 684 patients and the results showed that the incidence of AE-ILD in NSCLC-ILD patients was 8.07% similar to Chen`s study. The result is consistent with the research conducted by Hamada et_al which . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.